ContractCredit Agreement • June 13th, 2022 • DarioHealth Corp. • Surgical & medical instruments & apparatus • New York
Contract Type FiledJune 13th, 2022 Company Industry JurisdictionCERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (i) NOT MATERIAL AND (ii) is the type that DARIOHEALTH CORP. treats as private or confidential. OMISSIONS ARE DENOTED IN BRACKETS WITH ASTERISKS THROUGHOUT THIS EXHIBIT.
CREDIT AGREEMENT dated as of November 16, 2018 by and between TELA BIO, INC., as the Borrower, and ORBIMED ROYALTY OPPORTUNITIES II, LP, as the LenderCredit Agreement • October 15th, 2019 • TELA Bio, Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledOctober 15th, 2019 Company Industry JurisdictionTHIS CREDIT AGREEMENT dated as of November 16, 2018 (as amended, supplemented or otherwise modified from time to time, this “Agreement”), is by and between TELA BIO, INC., a Delaware corporation (the “Borrower”) and ORBIMED ROYALTY OPPORTUNITIES II, LP, a Delaware limited partnership (together with its Affiliates, successors, transferees and assignees, the “Lender”). The Borrower and the Lender are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
CREDIT AGREEMENT dated as of November 16, 2018 by and between TELA BIO, INC., as the Borrower, and ORBIMED ROYALTY OPPORTUNITIES II, LP, as the LenderCredit Agreement • August 16th, 2019 • TELA Bio, Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledAugust 16th, 2019 Company Industry JurisdictionTHIS CREDIT AGREEMENT dated as of November 16, 2018 (as amended, supplemented or otherwise modified from time to time, this “Agreement”), is by and between TELA BIO, INC., a Delaware corporation (the “Borrower”) and ORBIMED ROYALTY OPPORTUNITIES II, LP, a Delaware limited partnership (together with its Affiliates, successors, transferees and assignees, the “Lender”). The Borrower and the Lender are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
CREDIT AGREEMENT dated as of February 6, 2019 by and between HEALTH CATALYST, INC., as the Borrower, and ORBIMED ROYALTY OPPORTUNITIES II, LP,Credit Agreement • June 27th, 2019 • Health Catalyst, Inc. • Services-computer programming, data processing, etc. • New York
Contract Type FiledJune 27th, 2019 Company Industry JurisdictionTHIS CREDIT AGREEMENT dated as of February 6, 2019 (as amended, supplemented or otherwise modified from time to time, this “Agreement”), is by and between HEALTH CATALYST, INC., a Delaware corporation (the “Borrower”), and ORBIMED ROYALTY OPPORTUNITIES II, LP, a Delaware limited partnership (together with its successors, transferees and assignees, the “Lender”). The Borrower and the Lender are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
CREDIT AGREEMENT dated as of February 6, 2019 by and between HEALTH CATALYST, INC., as the Borrower, and ORBIMED ROYALTY OPPORTUNITIES II, LP,Credit Agreement • May 20th, 2019 • Health Catalyst, Inc. • Services-computer programming, data processing, etc. • New York
Contract Type FiledMay 20th, 2019 Company Industry JurisdictionTHIS CREDIT AGREEMENT dated as of February 6, 2019 (as amended, supplemented or otherwise modified from time to time, this “Agreement”), is by and between HEALTH CATALYST, INC., a Delaware corporation (the “Borrower”), and ORBIMED ROYALTY OPPORTUNITIES II, LP, a Delaware limited partnership (together with its successors, transferees and assignees, the “Lender”). The Borrower and the Lender are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.